Performance Characteristics of Seven Automated CA 125 Assays
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bast RC Jr, Feeney M, Laarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331-1337.
Nustad K, Bast RC Jr, O'Brien TJ, et al. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. Tumour Biol. 1996;17:196-219.
Bischof P. What do we know about the origin of CA 125? Eur J Obstet Gynecol Reprod Biol. 1993;49:93-98.
Kabawat SE, Bast RC Jr, Bhan AK, et al. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol. 1983;2:275-285.
Chan DW, Booth RA, Diamandis EP. Tumor markers. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. Philadelphia, PA: Saunders; 2005:745-795.
Van Kamp GJ, Verstraeten AA, Kenemans P. Discordant serum CA 125 values in commercial immunoassays. Eur J Obstet Gynecol Reprod Biol. 1993;49:99-103.
Kenemans P, Bon GG, Kessler AC, et al. Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125. Clin Chem. 1992;38:1466-1471.
Kenemans P, van Kemp GJ, Oehr P, et al. Heterologous double determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum. Clin Chem. 1993;39:2509-2513.
Uhl W, Denk B. Improved CA 125 determinations using two different monoclonal antibodies. In: Klapdor R, ed. Current Tumor Diagnosis: Applications, Clinical Relevance, Research Trends. Munich, Germany: Zuckschwerdt Verlag; 1994:384-388.
Kenemans P, Verstraeten AA, van Kamp GJ, et al. The second generation CA 125 assays. Ann Med. 1995;27:107-113.
Bonfrer JM, Baan AW, Jansen E, et al. Technical evaluation of three second generation CA 125 assays. Eur J Clin Chem Clin Biochem. 1994;32:201-207.